NCT04854629

Brief Summary

Osteoporotic vertebral fractures often lead to postural changes, chronic spinal pain conditions and limited functionality. Orthoses that straighten the spine have been shown in studies to have a positive effect on pain, posture and the functional state of patients with a fresh vertebral fracture. The planned study investigates the effect of the orthosis "Spinomed active" in patients aged ≥ 65 years with at least one non-acute osteoporotic vertebral fracture (at least 3 months ago) and chronic back pain.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 7, 2021

Completed
6 days until next milestone

First Submitted

Initial submission to the registry

April 13, 2021

Completed
9 days until next milestone

First Posted

Study publicly available on registry

April 22, 2021

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 15, 2021

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

January 15, 2022

Completed
Last Updated

January 19, 2022

Status Verified

January 1, 2022

Enrollment Period

8 months

First QC Date

April 13, 2021

Last Update Submit

January 18, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Back pain

    Change in back pain (mean intensity over 4 weeks on the "numeric pain scale (NPS) "0-10").

    At baseline and after 16 weeks (i.e. over 16 weeks)

Secondary Outcomes (6)

  • Trunk strength/performance

    At baseline and after 16 weeks (i.e. over 16 weeks)

  • Kyphosis angle

    At baseline and after 16 weeks (i.e. over 16 weeks)

  • Functional capacity

    At baseline and after 16 weeks (i.e. over 16 weeks)

  • Pulmonary function

    At baseline and after 16 weeks (i.e. over 16 weeks)

  • Everyday life skills

    At baseline and after 16 weeks (i.e. over 16 weeks)

  • +1 more secondary outcomes

Study Arms (2)

Spinomed active orthosis

EXPERIMENTAL

Wearing the orthosis for 16 weeks

Other: Spinomed active

Control group

NO INTERVENTION

No intervention: non spinomed active control

Interventions

Wearing of the orthosis 2-3 h/twice a day for 16 weeks Supplementation of a maximum of 1000 mg/d calcium and 800 IE/d vitamin D

Spinomed active orthosis

Eligibility Criteria

Age65 Years+
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsHigher incidence of osteopenia in female population
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • Living independently in the community
  • ≥ 1 low-traumatic vertebral fracture ≥ 3 months ago
  • Chronic back pain according to the national guideline for low back pain
  • Mean back pain intensity NPS ≥ 1 (1-10 scale)
  • Hyperkyphosis, kyphosis angle according to Debrunner \>40°
  • Intact skin or adequate wound coverage in the area of the contact surface of the orthosis

You may not qualify if:

  • Secondary osteoporosis (as determined by study physician)
  • Expected change in overall pain therapy during the study period
  • Structurally fixed kyphosis, lack of extension ability of the thoracic spine
  • Kyphoplasty, vertebroplasty
  • Use of back orthoses during the last 6 months
  • Depression
  • Dementia, cognitive impairment (Mini Mental Test \< 25)
  • Fresh neurological deficits; incontinence \> grade 1
  • Body dimensions that do not allow for adjustment of the back orthosis
  • Absence during baseline and follow-up assessments

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Institute of Medical Physics University of Erlangen-Nurnberg

Erlangen, 91052, Germany

Location

MeSH Terms

Conditions

Bone Diseases, MetabolicKyphosis

Condition Hierarchy (Ancestors)

Bone DiseasesMusculoskeletal DiseasesMetabolic DiseasesNutritional and Metabolic DiseasesSpinal CurvaturesSpinal Diseases

Study Officials

  • Wolfgang Kemmler, PhD

    Institute of Medical Physics, Friedrich-Alexander University of Erlangen-Nürnberg

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Outcomes assessor were unaware of participant status (i.e. spinomed active or control) and were not allowed to ask correspondingly
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: Randomized controlled trial with two study groups in parallel: (1) Spinomed active orthosis or 16 weeks (2) non spinomed active orthosis control
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 13, 2021

First Posted

April 22, 2021

Study Start

April 7, 2021

Primary Completion

December 15, 2021

Study Completion

January 15, 2022

Last Updated

January 19, 2022

Record last verified: 2022-01

Data Sharing

IPD Sharing
Will share

The data that support the findings of this study are available on request from the corresponding researcher (SW)

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR
Time Frame
Data will become available in March 2022 without time limit.

Locations